Our genomes are filled with errors that were once impossible to correct. But in CRISPR, we finally found an extraordinarily ...

Our Connections hints guide provides daily hints, tips, and answers to help you solve today's Connections puzzle on Monday, ...

The cells in living organisms are constantly making proteins. Ribosomes, the RNA-protein complexes that make other proteins, ...

This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).

Scientists have identified a microbe capable of interpreting a single piece of genetic code in two completely different ways, ...

As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea. The gene-editing technology ...

A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests could have quickly formed in the presence of compounds called borates. When ...

A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing inside human cells. These viruses include those ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research project that changed biology and chemistry forever. To understand what the ...

Research into how a father’s choices — such as diet, exercise, stress, nicotine use — may transfer traits to his children has become impossible to ignore. The standard sperm-meets-egg story posits ...

As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are looking to bacteriophages, viruses that infect bacteria, as an alternative.

GSK is joining Big Pharma’s year-end dealmaking rush, signing a pact with CAMP4 Therapeutics to advance novel RNA-targeting therapies for neurodegenerative and kidney diseases. The pharma will pay $17 ...